Home › Cardiomyopathy › Tennessee › Nashville
Cardiomyopathy clinical trials in Nashville, TN
5 studies for Cardiomyopathy are looking for participants at sites in and around Nashville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Sodium/Glucose Cotransporter-2 Inhibitors (SGLT2i) Therapy in Duchenne Cardiomyopathy
RecruitingPhase 1
- Vanderbilt University Medical Center, Nashville
Modeling Mortality in Duchenne Muscular Dystrophy Cardiomyopathy: Identification of Surrogate Outcome Measures for DMD Drug Trials
RecruitingObservational study
- Vanderbilt University Medical Center, Nashville
The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients
RecruitingPhase 4
- Vanderbilt University Medical Center, Nashville
Wearable Technology to Evaluate Hyperglycemia and HRV in DMD
RecruitingObservational studyHealthy volunteers welcome
- Vanderbilt University Medical Center, Nashville
Wearable Technology to Evaluate Hyperglycemia and HRV in DMD - Longitudinal Aim
RecruitingObservational study
- Vanderbilt University Medical Center, Nashville
About Cardiomyopathy
Cardiomyopathy is a disease that causes the heart to become enlarged, thick, or stiff. Read about the different types, their symptoms, and treatments.
More about Cardiomyopathy on MedlinePlus
Cardiomyopathy trials in other cities
- New York City, NY10 studies
- Boston, MA9 studies
- Washington, DC8 studies
- Rochester, MN8 studies
- Baltimore, MD7 studies
- San Diego, CA7 studies
- Richmond, VA6 studies
- Indianapolis, IN6 studies
- Dallas, TX6 studies
- St. Louis, MO6 studies
- Philadelphia, PA6 studies
- Charleston, SC6 studies
Other studies in Nashville
- Non-Small Cell Lung Cancer97 studies
- Breast Cancer81 studies
- Metastatic Cancer70 studies
- Colorectal Cancer69 studies
- Cancer (all types)65 studies
- Ovarian Cancer49 studies
- Prostate Cancer43 studies
- Lung Cancer40 studies
- Head and Neck Squamous Cell Carcinoma39 studies
- Pancreatic Cancer39 studies
- Endometrial Cancer38 studies
- Melanoma33 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.